Detalhe da pesquisa
1.
Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma.
Pharmacogenet Genomics
; 26(5): 243-7, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26928270
2.
Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study).
Cancers (Basel)
; 11(4)2019 Apr 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-30999660